A WIRED investigation purchased peptides from a Brooklyn bodega and sent them to an independent testing lab, which found that none of the four samples contained their claimed active ingredients, though they had low levels of contaminants. The results highlight risks in the largely unregulated peptide market, where turnkey services enable businesses to sell substances that may be mislabeled, degraded, or counterfeit.